A study, published in Annals of Internal Medicine, sought to identify novel protein biomarkers in stool that would detect colorectal cancer and advanced adenomas at a greater rate than hemoglobin.
GI & Endoscopy
Anesthesia Business Consultants President and CEO Tony Mira penned a blog post on the 2018 Medicare Physician Fee Schedule and its effects on reimbursement for gastroenterology anesthesia procedures.
John Vainder, MD, is a gastroenterologist at Illinois Gastroenterology Group in Evanston.
A study, presented at World Congress of Gastroenterology 2017, examined if endoscopic therapy would be effective for Barrett's esophagus patients with intramucosal carcinoma as it is for those with high-grade dysplasia.
The National Cancer Institute intends to commit $3 million in funding to advance colorectal cancer screening.
Advertisement
Here are the five most popular gastroenterology and endoscopy stories for the week of Nov. 13 to Nov. 17, 2017.
Here are three gastroenterologists making news this past week.
Sam Moussa, MD, is a gastroenterologist at Tucson, Ariz.-based Adobe Gastroenterology.
SGS United Kingdom withdrew GI Dynamics' CE Mark for its EndoBarrier device.
After announcing positive results from its second phase III trial, Global Data Healthcare Analysts' Maria Sudul said Ardelyx's Tenapanor is in line to make a "successful market entry."